Effects of high sucrose diet, gemfibrozil, and their combination on plasma paraoxonase 1 activity and lipid levels in rats

Acta Biochimica Polonica

Volumn 57, Issue 3, 2010, Pages 321-326

  Macan, Marija ^a   Vrkić, Nada ^b,c   Vrdoljak, Ana Lucić ^d   Radić, Božica ^d   Bradamante, Vlasta ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Gemfibrozil; High sucrose diet; Lipids; Paraoxonase

Indexed keywords

RATTUS;

EID: 77957924489     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2010_2411     Document Type: Article

References (46)

1. Allain CC, Poon LS, Chang CSG, Riomond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
2. Arnaiz SL, Travacio M, Llesuy S, Boveris A (1995) Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate. Biochem Biophys Acta 1272: 175-180.
3. Aviram M, Rosenblat M (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16: 393-399.
4. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J Clin Invest 101: 1581-1590.
5. Bachorik PS (1991) Measurement of low density lipoprotein cholesterol. In Handbook of lipoprotein testing. Rifai N, Warnic RG, Dominiczok H eds, pp 145-160. AACC Press, Washington.
6. Balogh Z, Seres I, Harangi M, Kovács P, Kakuk Gy, Paragh Gy (2001) Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? Diabetes Metab 27: 604-610.
7. Bar-On H, Stein Y (1994) Effect of glucose and fructose administration on lipid metabolism in the rat. J Nutrition 94: 95-105.
8. Beltowski J, Wójcicka G, Górny D, Marciniak A (2000) The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 51: 883-896.
9. Beltowski J, Wójcicka G, Mydlarczyk M, Jamroz A (2002) The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity. J Physiol Pharmacol 53: 463-475.
10. Beltowski J, Wojcicka G, Jamroz A (2004) Effect of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities. J Cardiovasc Pharmacol 43: 121-127.
11. Bradamante V, Vrkić N, Lucić A, Macan M (2005) Interrelated effects of high sucrose diet and gemfibrozil on butyrylcholinesterase activity and plasma lipids in rats. Period Biol 107: 189-193.
12. Busserolles J, Rock E, Gueux E, Mazur A, Grolier P, Rayssiguier Y (2002a) Short-term consumption of a high-sucrose diet has a prooxidant effect in rats. Br J Nutr 87: 337-342.
13. Busserolles J, Zimowska W, Rock E, Rayssiguier Y, Nazur A (2002b) Rats fed a high sucrose diet have altered heart antioxidant enzyme activity and gene expression. Life Sci 71: 1303-1312.
14. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT (2001) Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriacylglyceridemic patients. Eur J Clin Invest 31: 707-713.
15. Czok R, Barthelmai W (1962) Enzymatische Bestimmungen der Glucose in Blut, Liquor und Ham. Klin Wschr 40: 585-589.
16. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69: 541-550.
17. Dashti N, Ontko JA (1983) Alterations in rat serum lipids and apolipoproteins following clofibrate treatment. Atherosclerosis 49: 255-266.
18. Deakin S, Moren X, James RW (2005) Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Atherosclerosis 179: 17-25.
19. Diniz YS, Rocha KKHR, Souza GA, Galhardi CM, Ebaid GMX, Rodrigues HG, Novelli Filho JLVB, Cicogna AC, Novelli ELB (2006) Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 543: 151-157.
20. Durrington PN, Mackness MI, Bhatnagar D, Julier K, Prais H, Arrol S, Morgan J, Wood GNI (1998) Effects of two different fibric acid derivatives on lipoproteins, cholesterol ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinemia. Atherosclerosis 138: 217-225.
21. Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21: 473-480.
22. James RW, Deakin SP (2004) The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic Biol Med 37: 1986-1994.
23. James RW, Blatter Garin MC, Calabresi L, Miccoli R, von Eckardstein A, Tilly-Kiesi M, Taskinen MR, Assmann G, Franceschini G (1998) Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. Atherosclerosis 139: 77-82.
24. Kannan R, Baker N, Bruckdorfer KR (1981) Secretion and turnover of very low density lipoprotein triacylglycerols in rats fed chronically diets rich in glucose and fructose. J Nutr 111: 1216-1223.
25. Kawamura M, Miyazaki S, Teramoto T, Ashidate K, Thoda H, Ando N, Kaneko K (2000) Gemfibrozil metabolite inhibits in vitro lowdensity lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDL. Metabolism 49: 479-485.
26. Kissebah AH, Alfarsi S, Adams PW (1981) Integrated regulation of very low density lipoprotein triacylglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriacylglyceridemia and familial combined hyperlipidemia. Metabolism 30: 856-868.
27. Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, Mutanen M (2002) Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 160: 425-432.
28. Krause BR, Newton RS (1986) Gemfibrozil increases both apoA-I and apo E concentrations. Comparison to the other lipid regulators in cholesterol-fed rats. Atherosclerosis 59: 95-98.
29. Krause BR, Barnett BC, Essenburg AD, Kieft KA, Auerbach BJ, Bousley R, Stanfield R, Newton RS, Bisgaier CL (1996) Opposite effects of bezafibrate and gemfibrozil in both non and hypertriacylglyceridemic rats. Atherosclerosis 127: 91-101.
30. Kudchodkar BJ, Lacko AG, Dory L, Fungwe TV (2000) Dietary fat modulates serum paraoxonase 1 activity in rats. J Nutr 130: 2427-2433.
31. Lock EA, Mitchell AM, Elcombe CR (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29: 145-163.
32. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7: 69-76.
33. Mackness B, Hine D, McElduff P, Mackness M (2006) High C-reactive protein and low paraoxonase 1 in diabetes as risk factors for coronary heart disease. Atherosclerosis 186: 396-401.
34. McElveen J, Mackness MI, Colley CM, Peard T, Warner S, Walker CH (1986) Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem 32: 671-673.
35. Ozansoy G, Akin B, Aktan F, Karasu Ç (2001) Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem 216: 59-63.
36. Paragh G, Seres I, Harangi M, Balogh Z, Illyés L, Boda J, Szilvássy Z, Kovács P (2003) The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease. Diabetes Metab 29: 613-618.
37. Petit D, Bonnefis MT, Rey C, Infante R (1988) Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normoand hyperlipidemic rats. Atherosclerosis 74: 215-225.
38. Reisen WF (1998) Lipid metabolism. In Clinical laboratory diagnostics. Use and assessements of clinical laboratory results; pp 169-172. TH-books Verlasgesellschaft, Frankfurt/Main.
39. Saku K, Okamoto T, Takeda Y, Jimi S, Zhang B, Bai H, Liu R, Arakawa K (1996) Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triacylglyceride lipase in rats. Artery 22: 36-48.
40. Scatena R, Nocca G, De Sole P, Fresu R, Zuppi C, Giardina B (1997) The priming effect of gemfibrozil on reactive oxygen metabolism of phagocytic leucocytes. An intriguing side effect. Clin Chim Acta 226: 173-183.
41. Shephard MDS, Whiting MJ (1990) Falsely low estimation of triacylg lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen. Clin Chem 36: 325-329.
42. Soran H, Younis NN, Charlton-Menys V, Durrington P (2009) Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 20: 265-274.
43. Staels B, van Tol A, Andreu T, Auwerx J (1992) Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissueselective manner in the rat. Arterioscler Thromb Vasc Biol 12: 286-294.
44. Strobl W, Gorder NL, Fienup GA, Lin-Lee Y-C, Gotto AM, Patsch W Jr (1989) Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. J Biol Chem 264: 1190-1194.
45. Tellone E, Ficarra S, Giardiana B, Scatena R, Russo A, Clementi ME, Misiti F, Bellocco E, Galtieri A (2008) Oxidative effects of gemfibrozil on anion influx and metabolism in normal and beta-thalassemic erythrocytes: physiological implications. J Memb Biol 224: 1-8.
46. Yoshida H, Ishikawa T, Ayaori M, Shige H, Ito T, Suzukawa M, Nakamura H (1998) Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a tandomized, double-blind, placebo-controlled study. Atherosclerosis 139: 179-187.